Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTEG- Bloodless Glucose Monitor -- Ignore unavailable to you. Want to Upgrade?

To: BitWizrd who wrote (152)	6/11/1998 11:14:00 AM
From: nestegg	Respond to of 176

OK! ...hopefully your describing NTEG original Prototype, and these 'objections' have been designed out in protos #2, #3 ....! Hopefully, someone at NTEG is assigned gathering and analysis of Competitors' Products? Know your Competition! "Build a Better mouse-trap!" (Hum! ... did'nt realize their was a disposable cost.) At least, a diabetics FINGERS are saved from further torture!

To: BitWizrd who wrote (152)	6/11/1998 3:34:00 PM
From: Steve Hudson	Read Replies (3) \| Respond to of 176

Draw your own conclusions: 1) The needle used in the Lifeguide key punctures only the outer layer of skin, to the dermis, approximately 1.4 millimeters. It does not reach far enough to intrude where capillaries and nerve endings are numerous. People who have used it describe the feeling as "a mild pinch," a "tweak," "a pressure point," etc. Is this the pain associated with traditional fingerprick techology? 2) The Lifeguide is not completely noninvasive: no platform which takes a physilogical sample will be, unless ISF can be "sucked out" by a chemical means. 3) The Lifeguide monitor is similar in size to a hand held cellular phone. Is it portable? 4) NTEG has stated that they will price the monitor and keys to make it competitive with existing technologies. Would such a device be a substantial improvement to the quality of life of many people? Steve